Buy, Sell, Or Hold HIMS Stock At $60?
1. Hims & Hers stock surged 43% after Super Bowl ad. 2. Revenue rose 357% from $272 million in 2021 to $1.2 billion. 3. Compounded semaglutide treatment offers competitive pricing at $165. 4. User base expanded from 0.5 million to over 2 million since 2021. 5. Weight-loss drug shortages could benefit Hims & Hers's compounded alternatives.